NOS3 and colorectal carcinoma: In addition, some studies have demonstrated in ex vivo experiments that the combination of CBD and oxaliplatin treatment of CRC cells can reduce nitric oxide synthase 3 (NOS3) activity, leading to mitochondrial dysfunction-mediated ROS production and excessive ERS, and ultimately induce autophagy, and thus it has an antitumor role [34].